The "gold standard" for schizophrenia treatment varies by condition: Clozapine is the gold standard medication for treatment-resistant schizophrenia (TRS) due to its superior efficacy in reducing symptoms and suicide risk, while Cognitive Behavioral Therapy (CBT), combined with medication, is a gold standard psychosocial approach for managing overall symptoms and improving functioning, often in conjunction with antipsychotics. For general diagnosis and research, the Positive and Negative Syndrome Scale (PANSS) serves as a gold standard assessment tool.
Antipsychotics are the gold standard treatment for schizophrenia, but many patients who receive treatment experience persistent symptoms.
The PANSS, SAPS, and SANS are well-established scales that have been used to objectively assess for schizophrenia symptoms. The fact that it is sensitive to change makes it a “gold standard” in treatment studies.
Medicines are the main schizophrenia treatment. Antipsychotic medicines are the most prescribed drugs. They're thought to control symptoms mainly by affecting brain receptors for different neurotransmitters, or chemical messengers. Most antipsychotic medications act on dopamine and serotonin receptors.
In addition to efficacy in treatment resistance, clozapine is shown to decrease suicide risk, maintaining the Food and Drug Administration (FDA) label for reducing risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder (Meltzer, et al., 2003).
Five constructs (the 5 “A”) were identified as negative symptoms namely affect (blunted), alogia, anhedonia, asociality, and avolition and were clustered into two factors: one including blunted affect and alogia and the other consisting of anhedonia, avolition, and asociality (Table 1).
The "25 rule" (or "rule of quarters") in schizophrenia describes the varied long-term outcomes, suggesting roughly 25% fully recover, 25% significantly improve with some support, 25% need substantial ongoing care due to relapses, and the final 25% have a chronic, poor prognosis, with a portion leading to disability or suicide. This concept evolved from the older "rule of thirds" as treatment improved, highlighting that outcomes are diverse, and many individuals can achieve significant recovery with proper management.
Note: Clozapine is the only FDA-approved medication for treating schizophrenia that is resistant to other treatments.
Stress. The main psychological triggers of schizophrenia are stressful life events, such as: bereavement. losing your job or home.
Clozapine may cause drowsiness, blurred vision, convulsions (seizures), or to have trouble with thinking or controlling body movements, which may lead to falls, fractures or other injuries.
In September 2024, the FDA approved the first treatment for schizophrenia with no direct D2R-blocking activity: the dual M1/M4 muscarinic acetylcholine receptor (mAChR) agonist xanomeline in combination with the peripherally restricted pan mAChR antagonist trospium chloride.
One simple way to remember the criteria in defining psychological disorders are the four D's: deviance, dysfunction, distress, and danger (and possibly even a fifth D for the duration).
That's because some early symptoms of schizophrenia — those that occur before hallucinations, delusions and disorganization — are commonly seen in many teens, such as:
Regularly drinking more than the recommended amount of alcohol or using illegal drugs can trigger psychosis and make symptoms of schizophrenia worse. Alcohol and drug use can also cause other mental health problems, such as depression and anxiety as well as causing damage to your physical health.
Clozapine is often the last resort for people with schizophrenia who haven't responded to other medications. For many, it is life-changing – reducing symptoms, hospitalisations, and even suicide risk.
Most people with schizophrenia are never violent and indeed do not display any dangerous behaviour. However a small number do become violent when they are suffering from the acute symptoms of psychosis because of the influence of the hallucinations and delusions on their thinking.
Auditory hallucinations, or “hearing voices,” are the most common in schizophrenia and related psychotic disorders. Disorganized thinking and speech refer to thoughts and speech that are jumbled or do not make sense.
Scientists believe that people with schizophrenia have an imbalance of the neurotransmitters (brain chemicals) serotonin, dopamine, and glutamate. These neurotransmitters allow nerve cells in the brain to send messages to each other.
This can be a passive diversion, for example watching television, listening to music, using headphones or relaxation. Alternatively the distraction can involve activity such as playing an instrument, writing, reading, gardening, walking or any form of exercise.
Cobenfy is the first treatment for the disease to use a new mechanism to ease symptoms, such as hearing voices and hallucinations, without debilitating side effects.
Schizophreniform disorder.
People with schizophreniform disorder have the same symptoms as people with schizophrenia. But their illness episodes do not last as long (from 1 to 6 months), and they may not have as many problems getting along with other people.
There's no single test for schizophrenia and the condition is usually diagnosed after assessment by a specialist in mental health. If you're concerned you may be developing symptoms of schizophrenia, see a GP as soon as possible. The earlier schizophrenia is treated, the better.
Early diagnosis and appropriate treatment make it possible to recover from psychosis. Some people who receive early treatment never have another psychotic episode. For other people, recovery means the ability to live a fulfilling and productive life, even if psychotic symptoms sometimes return.
Disability Ratings for Schizophrenia
100% disability rating: a 100% disability rating for this condition is assigned when the veteran suffers total occupational and social impairment.